Form 8-K General Growth Propertie For: Aug 03
http://archive.fast-edgar.com/20150803/AWUNH22CZ22QP2Z2222R22ZZ2UIAZZI26272
Filed on: August 3, 2015
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026
- Bitcoin Price Prediction: Fidelity Tracks 135,979 BTC Bought via Preferred Shares as Remittix Earn Targets Up to 22% APY
- CatalYm Presents Phase 2 Data Showing Visugromab Substantially Enhances the Clinical Benefit of PD-1 Inhibition in Neoadjuvant Bladder Cancer at ESMO 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share